Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting intervention description across studies assessing the impact of clinical pharmacy activities. |
| Full bibliographic reference | Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21(4):584-590. |
| Language | English |
| PubMed ID | 25676042 |
| Reporting guideline acronym | DEPICT 2 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Pharmaceutical medicine |
| Applies to the whole report or to individual sections of the report? | Intervention (exposure) |
| Previous versions of this guideline / Guideline history | An earlier version of this reporting guideline was published in 2013: Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7-8):946-952. PMID: 23757389 |
| Record last updated on | November 26, 2021 |